The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts
- 1 February 2003
- Vol. 32 (2) , 136-141
- https://doi.org/10.1016/s8756-3282(02)00953-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Bone Remodeling and Structure in Postmenopausal Women Treated with Long-Term, High-Dose Estrogen TherapyOsteoporosis International, 1999
- Real-time quantitative RT–PCR after laser-assisted cell pickingNature Medicine, 1998
- TRANCE Is Necessary and Sufficient for Osteoblast-mediated Activation of Bone Resorption in OsteoclastsThe Journal of Experimental Medicine, 1998
- A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionNature, 1997
- The effect of long term oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomyBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- Isolation of a Novel Cytokine from Human Fibroblasts That Specifically Inhibits OsteoclastogenesisBiochemical and Biophysical Research Communications, 1997
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997
- The effects of long-term hormone replacement therapy on bone remodeling in postmenopausal womenBone, 1996
- 17β Estradiol stimulation of endosteal bone formation in the ovariectomized mouse: An animal model for the evaluation of bone-targeted estrogensBone, 1992
- Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation.Journal of Clinical Investigation, 1992